1-ethyl-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 100mg

Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone, 98%, 250mg

Matraces de fondo redondo con doble cuello, 100 ml, 29/32, 29/32, 1 Pieza

2-(2,5-Dibromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

N~1~,2-dimethylalaninamide hydrochloride, 95.0%, 5g

6-Bromo-2-phenylimidazo[1,2-a]pyridine, 95.0%, 1g

Lithium(1+) 1-(4-chlorophenyl)-1H-imidazole-2-carboxylate, >95%, 1g

1-Ethylazetidin-3-amine dihydrochloride, 98%, 250mg

2-Bromo-4-fluoro-5-nitrobenzoic acid, 95.0%, 5g

4,4'-(1,2-Diphenylethene-1,2-diyl)diphenol (cis- and trans- mixture)>95.0%(HPLC)200mg

(αR)-4-Bromo-α,3-dimethylbenzenemethanol, 250mg

1-Boc-4-Phenylpiperazine, 95.0%, 25g

1-(4-Aminophenyl)hexan-1-one, 98%, 5g